Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk

J Intern Med. 2020 Jun;287(6):746-747. doi: 10.1111/joim.13070. Epub 2020 Apr 22.

Authors

Alpo Vuorio^{1

2}, Gerald F Watts^{3

4}, Petri T Kovanen⁵

Affiliations

¹ From the, Mehiläinen Airport Health Centre, Vantaa, Finland.
² Department of Forensic Medicine, University of Helsinki, Helsinki, Finland.
³ Faculty of Medicine and Health Sciences, School of Medicine, University of Western Australia, Perth, WA, Australia.
⁴ Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, WA, Australia.
⁵ Wihuri Research Institute, Helsinki, Finland.

PMID: 32242993
DOI: 10.1111/joim.13070

No abstract available

Publication types

Letter

MeSH terms

Betacoronavirus*
COVID-19
Cardiovascular Diseases / etiology*
Coronavirus Infections / complications*
Humans
Hyperlipoproteinemia Type II / complications*
Hyperlipoproteinemia Type II / virology
Pandemics
Pneumonia, Viral / complications*
SARS-CoV-2